In the UK, one in 50 adults is living with a chronic wound,1 leading to more than £8 billion in healthcare costs in 2017/2018.2 However, these numbers are likely to be
New technologies are bringing into effect rapid change across the pharma industry, but no other aspect of the business is seeing innovation at the scale and speed of the clinical trial spac
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.